Johnson & Johnson Announces Completion of Synthes Acquisition
19-Jun-2012
- Switzerland
Under the terms of the agreement, each share of Synthes common stock will be exchanged for CHF 55.65 in cash and 1.7170 shares of Johnson & Johnson common stock. Cash will be provided for fractional shares.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.